|
IL10 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.562950E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.578000E-01 |
| Normal-vs-Stage2 |
4.658000E-03 |
| Normal-vs-Stage3 |
1.743640E-01 |
| Normal-vs-Stage4 |
4.122000E-01 |
| Stage1-vs-Stage2 |
1.598550E-04 |
| Stage1-vs-Stage3 |
5.873800E-01 |
| Stage1-vs-Stage4 |
8.872600E-01 |
| Stage2-vs-Stage3 |
1.992050E-02 |
| Stage2-vs-Stage4 |
3.117800E-02 |
| Stage3-vs-Stage4 |
6.272000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.188000E-01 |
| Normal-vs-AfricanAmerican |
4.220400E-01 |
| Normal-vs-Asian |
6.454200E-02 |
| Caucasian-vs-AfricanAmerican |
7.662000E-01 |
| Caucasian-vs-Asian |
7.215700E-02 |
| AfricanAmerican-vs-Asian |
6.934000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.599600E-01 |
| Normal-vs-Female |
1.216770E-01 |
| Male-vs-Female |
4.816400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.718400E-01 |
| Normal-vs-Age(41-60Yrs) |
5.776200E-02 |
| Normal-vs-Age(61-80Yrs) |
2.496600E-01 |
| Normal-vs-Age(81-100Yrs) |
4.389800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.286180E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.042200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.411180E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.619200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.480170E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.396800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.850200E-01 |
| Classical-VS-Follicular |
1.17680000188969E-08 |
| Classical-VS-Other |
6.21889999999903E-05 |
| Classical-VS-Normal |
3.870200E-01 |
| Tall-VS-Follicular |
1.253560E-02 |
| Tall-VS-Other |
1.028160E-02 |
| Tall-VS-Normal |
4.120000E-01 |
| Follicular-VS-Other |
6.603800E-01 |
| Follicular-VS-Normal |
1.721630E-03 |
| Other-VS-Normal |
1.459140E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.713800E-02 |
| Normal-vs-N1 |
8.006500E-02 |
| N0-vs-N1 |
7.939200E-01 |
|
|
